methylphenidate

(redirected from Ritalin la)
Also found in: Dictionary, Thesaurus.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

/meth·yl·phen·i·date/ (meth″il-fen´ĭ-dāt) a central stimulant, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.

methylphenidate

a central nervous system stimulant used in the treatment of hyperkinesis and narcolepsy in dogs.
References in periodicals archive ?
However, with a half-life of 2-3 hours, multiple doses are necessary during the school day Recently, the Food and Drug Administration approved several extended-release forms with the brand names Concerta, Metadate CD, and Ritalin LA.
Silva and his colleagues compared Concerta 18 mg, Concerta 36 mg, and Ritalin LA 20 mg vs.
The study was sponsored by Novartis, manufacturer of Ritalin LA, and published in Paediatric Drugs (5[8]:545-55, 2003).
Clinical studies showed Ritalin LA to be statistically superior to placebo (sugar pill) in managing the symptoms for both diagnostic subtypes of ADHD - ADHD Combined Type and ADHD Predominantly Inattentive Type.
Celgene Corporation (Nasdaq: CELG) of Warren, New Jersey granted Novartis Pharma AG an exclusive worldwide (excluding Canada) license covering its intellectual property rights associated with Ritalin LA as well as Focalin.
Novartis Pharmaceuticals Corporation has commercialization rights to Ritalin LA in the U.
Patients then were randomized in a double-blind fashion to either once-daily Ritalin LA or placebo for 2 weeks, Dr.
Parent, teacher, and investigator assessments found significantly greater improvements in ADHD symptoms in the Ritalin LA group compared with placebo.
The maker of Ritalin LA, Novartis Pharmaceuticals Corp.
Ritalin LA is effective in treating ADHD symptoms throughout the school day, eliminating the need for children to take their medication while in school.
Each bead-filled capsule of Ritalin LA provides an immediate release of Ritalin for rapid onset of action, and a second release of the medication approximately four hours after administration.
A double-blind, placebo-controlled study involving 134 patients, aged 6 to 12 years, demonstrated Ritalin LA to be effective in treating ADHD symptoms.